Cargando…
Lipid Formulations and Bioconjugation Strategies for Indomethacin Therapeutic Advances
Indomethacin (IND) is a drug which after successful clinical trials became available for general prescription in 1965 and from that time is one of the most widely used anti-inflammatory drug with the highest potencies in the in vitro and in vivo models. However, despite its high therapeutic efficacy...
Autores principales: | Gliszczyńska, Anna, Nowaczyk, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998224/ https://www.ncbi.nlm.nih.gov/pubmed/33809343 http://dx.doi.org/10.3390/molecules26061576 |
Ejemplares similares
-
Dexibuprofen Therapeutic Advances: Prodrugs and Nanotechnological Formulations
por: Gliszczyńska, Anna, et al.
Publicado: (2021) -
Evaluation of the Physico-Chemical Properties of Liposomes Assembled from Bioconjugates of Anisic Acid with Phosphatidylcholine
por: Pruchnik, Hanna, et al.
Publicado: (2021) -
Formulation and evaluation of indomethacin biomicroparticles
por: Gupta, Sudeep, et al.
Publicado: (2012) -
Recent Advances in Bioorthogonal Ligation and Bioconjugation
por: Zielke, Florian M., et al.
Publicado: (2023) -
Formulation Development and Release Studies of Indomethacin Suppositories
por: Sah, M. L., et al.
Publicado: (2008)